Drawing for CHLOR-TRIN

USPTO serial 77843993

CHLOR-TRIN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MCCAULEY, BRENDAN D
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CHLOR-TRIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Allergy capsules; Allergy medications; Allergy relief medication; Allergy tablets; Anti-cough drops; Antihistamines; Cough drops; Cough expectorants; Cough lozenges; Cough syrups; Cough treatment preparations; Decongestant capsules; Decongestant nasal sprays; Decongestants; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for tablets that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Expectorants; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for ophthalmological use; Pharmaceutical products for treating respiratory diseases and asthma; Preparations for the treatment of asthma; Preparations for treating coldsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 12, 2010MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Oct 12, 2010ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 12, 2010OP.TOPPOSITION TERMINATED NO. 999999—
Oct 12, 2010OP.SOPPOSITION SUSTAINED NO. 999999—
Jun 17, 2010OP.IOPPOSITION INSTITUTED NO. 999999—
Mar 17, 2010ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 9, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 9, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 30, 2010ALIEASSIGNED TO LIE—
Jan 7, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 6, 2010DOCKASSIGNED TO EXAMINER—
Oct 16, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance